Analyst consensus rating
MacroGenics Analyst Rating: Buy
MGNX is rated Buy by 4 analysts with a $7.25 target. As of 2026-08-24.
Direct answer
MacroGenics's consensus rating is Buy.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.25.
Forecast evidence checked August 24, 2026.
Get free MacroGenics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.10
- Average price target
- $7.25
- High price target
- $11.00
- Low price target
- $4.00
- Low target gap
- -2.4%
- Target upside
- +76.8%
- High target gap
- +168.3%
- Target range width
- 170.7%
- Consensus rating
- Buy
- Analysts
- 4
- Evidence date
- August 24, 2026
- Valid through
- August 31, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for MacroGenics?
MacroGenics has a verified Buy consensus. The same dataset has an average price target of $7.25.
How far are MacroGenics's low and high targets from the recorded price?
The low target implies -2.4%, while the high target implies +168.3%.
How many analysts are included in MacroGenics's consensus?
The verified consensus includes 4 analysts.
How is MacroGenics's target upside or downside calculated?
The average target of $7.25 is divided by the recorded price of $4.10, then one is subtracted to produce +76.8%. This does not guarantee a future return.
When was MacroGenics's analyst forecast verified?
The data was verified on 2026-08-24. The dataset is valid through 2026-08-31.